首页 | 本学科首页   官方微博 | 高级检索  
检索        

次级淋巴组织趋化因子及其受体CCR7在肿瘤侵袭和淋巴转移中的研究进展
引用本文:赵文华,李胜,衣龙海.次级淋巴组织趋化因子及其受体CCR7在肿瘤侵袭和淋巴转移中的研究进展[J].国际外科学杂志,2007,34(5):349-354.
作者姓名:赵文华  李胜  衣龙海
作者单位:250117,济南,山东省肿瘤医院肝胆外科;250117,济南,山东省肿瘤医院肝胆外科;250117,济南,山东省肿瘤医院肝胆外科
基金项目:国家自然科学基金资助项目(No.30571712)、山东省优秀中青年科学家科研奖励基金资助项目(No.2005BS03003)、山东省卫生厅资助项目(No.2005-169)
摘    要:次级淋巴组织趋化因子(SLC)是近年发现的一种新的趋化因子,高表达于次级淋巴组织,能趋化并活化T淋巴细胞、树突状细胞和自然杀伤细胞等免疫效应细胞,在机体淋巴细胞的迁移归巢、抗肿瘤、抗感染过程中具有重要作用。CCR7是SLC的高亲和力受体,近年来研究发现,CCR7和SLC的表达与肿瘤的淋巴转移密切相关。现综述SLC及其受体CCR7的生物学特性和主要功能,并重点阐述SLC和CCR7在肿瘤侵袭和淋巴转移中的研究现状。

关 键 词:次级淋巴组织趋化因子  CCR7  淋巴转移  淋巴管形成
修稿时间:2006-02-10

The advances of secondary lymphoid-tissue chemokine and its receptor CCR7 in tumor invasion and lymphatic metastasis
ZHAO Wen-Hua,LI Sheng,YI Long-Hai.The advances of secondary lymphoid-tissue chemokine and its receptor CCR7 in tumor invasion and lymphatic metastasis[J].International Journal of Surgery,2007,34(5):349-354.
Authors:ZHAO Wen-Hua  LI Sheng  YI Long-Hai
Institution:Department of Hepatobiliary surgery , Shandong Tumor Hospital ,Shandong 250117,China
Abstract:Secondary lymphoid-tissue chemokine(SLC)is a recently identified CC chemokine that is highly expressed in secondary lymphoid tissues and it can chemoattract and activate T lymphocytes, dendritic cells and natural killer cells. It plays an important role in the process of lymphocyte immigration and homing, anti-tumor and anti-infection.CCR7 is the high affinity receptor of SLC. There is a close correlation between the expression of CCR7 and SLC and tumor lymphatic metastasis. This article describes the bionomics and functions of SLC and CCR7, and reviews the advances of SLC and its receptor CCR7 in tumor invasion and lymphatic metastasis.
Keywords:secondary lymphoid-tissue chemokine  CCRT  lymphatic metastasis  lymphangiogenesis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号